Join
Live feed
·
INSIDERFilingvia Quantisnow
Quince Therapeutics Inc. logo

SEC Form 4: Hannah Brendan bought $87,550 worth of shares (71,762 units at $1.22), increasing direct ownership by 55% to 201,555 units

ByQuantisnow·Wall Street's wire, on your screen.
QNCX· Quince Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QNCX (Quince Therapeutics Inc.) and more on Quantisnow.